LOX and hydrops fetalis: Considering the negative impact of an excessive LOX/LOXL-mediated crosslinking of collagen on cardiac function, pharmacological strategies targeting LOX/LOXLs raise as promising therapeutic tools in patients with HF, as discussed below.